Kite Pharma Reports Fourth Quarter and Full-Year 2015 Financial Results
29 févr. 2016 16h01 HE
|
Kite Pharma, Inc.
- Interim KTE-C19 Data, Expected in Second Half of 2016, to Support Planned BLA Filing in Late 2016 and Potential Product Launch in 2017 - ...
Kite Pharma Augments Commercial Leadership Team
24 févr. 2016 17h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous cell therapy (eACT™)...
Kite Pharma to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016
24 févr. 2016 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that it will report fourth quarter and full year 2015 financial results on Monday,...
Kite Pharma to Participate in the 2016 RBC Capital Markets Global Healthcare Conference
16 févr. 2016 16h31 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that David D. Chang, M.D., Ph.D., Executive Vice President, Research and Development,...
Kite Pharma and Leiden University Medical Center Sign Research and License Agreement for T Cell Receptors Targeting HPV-Associated Cancers
13 janv. 2016 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that its European subsidiary has entered into a research and license agreement with Leiden...
Kite Pharma Expands Its Clinical and Research Partnership With the National Cancer Institute (NCI) for Next-Generation CAR Programs to Treat B-Cell Malignancies
07 janv. 2016 10h26 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI...
Kite Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference
06 janv. 2016 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will...
Kite Pharma Appoints Industry Leader Shawn Cline Tomasello as Chief Commercial Officer
21 déc. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that it has appointed Shawn Tomasello to the newly created position of Chief Commercial...
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
11 déc. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that the underwriters of its previously announced underwritten public offering have exercised...
Kite Pharma Announces Pricing of Public Offering of Common Stock
10 déc. 2015 08h00 HE
|
Kite Pharma, Inc.
SANTA MONICA, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced the pricing of an underwritten public offering of 3,625,000 shares of its common stock at a...